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Nuclear export: DNA-binding domains find a surprising partner 
Donald B. DeFranco 
Calreticulin, a calcium-binding protein of the
endoplasmic reticulum, has been found to function as a
nuclear export factor for a large family of nuclear
receptors. Atypical nuclear export pathways may thus
exist that regulate the compartmentalization and
activity of a distinct set of transcription factors.
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The transport of proteins between the nuclear and cyto-
plasmic compartments is mediated by a number of related
nuclear transport factors [1,2]. While their cargo and bio-
logical functions may be unique, the transport factors that
participate in nuclear import — the importins — or export
— the exportins — have common structural features that
direct their interactions with components of the nuclear
pore complex and the small monomeric GTP-binding
protein, Ran [3]. The predominant pathway for nuclear
protein export appears to be driven by the export factor
Crm1, which recognizes a leucine-rich nuclear export signal
sequence (NES) [1,2].
Recent work from Bryce Paschal’s group [4] has expanded
the repertoire of nuclear transport factors to include cal-
reticulin, a calcium-binding protein initially found to reside
predominantly within the endoplasmic reticulum [5]. Cal-
reticulin is unrelated in sequence to previously described
nuclear import and export factors [4]. Pashcal and co-
workers identified calreticulin in their search for novel
nuclear export factors using an in vitro nuclear export assay
[4]. Initially, calreticulin was found to be able to substitute
for Crm1, the prototypic nuclear export factor, in the
in vitro nuclear export of the protein kinase inhibitor
peptide, PKI. A mechanism for calreticulin’s effects on
PKI nuclear export was provided by data showing a direct
interaction in vitro between calreticulin, a functional NES
and Ran–GTP [4]. Calreticulin thus acts as a bona fide
nuclear export factor in forming a complex with Ran–GTP
when bound to an NES-containing cargo. 
While calreticulin can be used by exporting substrates that
participate in the Crm1 pathway, it also appears to be the
major export factor for nuclear hormone receptors. Inter-
estingly, the initial discoveries linking calreticulin and
nuclear hormone receptors did not implicate calreticulin in
receptor export. In 1994, two groups [6,7] simultaneously
reported their surprising findings of an inhibitory effect of
calreticulin on the transactivation of nuclear hormone
receptors. In vitro DNA-binding assays indicated that
recombinant calreticulin could inhibit DNA binding by
the androgen receptor, suggesting that calreticulin’s effects
on nuclear hormone receptor transactivation might be
direct. Consistent with this, the calreticulin-binding region
of nuclear receptor molecules was localized within a highly
conserved region of their DNA-binding domain. Impor-
tantly, the calreticulin-interaction domain was included
with a segment of the nuclear receptor DNA-binding
domain — the DNA-recognition helix — that is essential
for high-affinity DNA binding. Binding of nuclear receptor
molecules to DNA or calreticulin should thus be mutually
exclusive events.
Before the findings of Paschal’s group [4], the mechanism
of nuclear protein export of nuclear hormone receptors had
not been established and was a source of controversy in
the field [8–10]. The glucocorticoid receptor, for example,
does not appear to contain a leucine-rich NES, and in one
study its export was found to be insensitive to lepto-
mycin B, a specific inhibitor of the Crm1-dependent nuclear
export [10]. Using a combination of in vitro and in vivo
nuclear export assays and analysis of glucocorticoid recep-
tor export in calreticulin-deficient cells, Paschal’s group [4]
provided compelling evidence for calreticulin’s role in glu-
cocorticoid receptor nuclear export. Consistent with the
previous results which localized the calreticulin recogni-
tion motif within the glucocorticoid receptor DNA-binding
domain [6,7], the calreticulin-dependent nuclear export
signal of nuclear receptors was indeed found to be con-
tained within their DNA-binding domain [4]. Calreticulin
thus plays a dual role in limiting glucocorticoid receptor
function by inhibiting its DNA-binding and mediating its
removal from the nuclear compartment. It is unclear
whether calreticulin uses a distinct pathway for the nuclear
export of glucocorticoid receptor molecules, on the one
hand, and leucine-rich NES cargo on the other, as the
involvement of Ran–GTP in calreticulin-dependent nuclear
export of glucocorticoid receptor has not been assessed.
In a study published recently in Current Biology, Paschal
and co-workers [11] have now established calreticulin as
an export factor for multiple nuclear hormone receptors,
including steroid hormone, non-steroid hormone and
orphan receptors. Importantly, they have shown that a
highly conserved pair of adjacent phenylalanine residues
within the DNA-recognition helix of nuclear receptors is
critical for calreticulin binding in vitro and nuclear export
in vivo. The apparent relatedness of nuclear export
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mechanisms for diverse members of the nuclear receptor
superfamily implies that a competition could exist between
different nuclear receptors for limiting amounts of the
export factor calreticulin. As shown in carefully designed
in vivo and in vitro co-expression studies [11], competition
for binding calreticulin between glucocorticoid receptor and
vitamin D receptor molecules can limit nuclear export of
the glucocorticoid receptor and influence the efficacy of
glucocorticoid receptor transactivation. The extent to which
competition for calreticulin contributes to cross-talk among
the various nuclear receptors remains to be established in
systems where biological relevance can be assessed.
Calreticulin is unique among nuclear export factors for its
participation in so many diverse cellular functions. While
calreticulin does not appear to be strictly confined to the
endoplasmic reticulum, the extent of its nuclear localiza-
tion remains controversial [4,12,13]. Furthermore, the
mechanisms by which calreticulin molecules are imported
into, and retained in, the nucleus are undefined. Deletion
of the amino-terminal signal sequence of calreticulin
appears to eliminate the protein’s effects on glucocorticoid
receptor transactivation in transiently transfected cells
[13], but does not influence its function as a nuclear export
factor for the glucocorticoid receptor (B. Paschal, personal
communication). 
It is thus unclear whether nuclear localization of calretic-
ulin is driven by its simple exclusion from the endoplasmic
reticulum import machinery — via elimination of its
amino-terminal signal sequence — or by its retrotransloca-
tion from the endoplasmic reticulum to the cytoplasm. In
recent years, our view of strict protein compartmentaliza-
tion has been challenged as proteins that localize to focal
adhesions [14–16], endosomes [17] and plasma membrane
[18] have been found to shuttle between the nuclear and
cytoplasmic compartments. Calreticulin may have a similar
capacity to localize to distinct subcellular compartments
and act independently on compartment-specific targets. In
fact, the limiting amounts of calreticulin within the nucleus
may be biologically relevant, given the relatively inefficient
nuclear export of nuclear hormone receptors [19].
It is unclear why nuclear hormone receptors would have
evolved such a distinct mechanism for nuclear export,
given the diversity of related nuclear transport factors that
accommodate a wide range of distinct cargoes. Perhaps the
export of nuclear hormone receptors is linked to other
processing steps that impact on subnuclear transport
[10,20] of the receptors or their productive interactions
with the transcriptional machinery. The increased diver-
sity in mechanisms of nuclear protein export highlighted
by the studies of Paschal’s group [4,11] suggest that many
more surprises await as more details of protein transport
within the nucleus are uncovered. 
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